Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

AbbVie Inc.

TRADE

NYSE: ABBVHealthcare / Drug Manufacturers - Major / USA
91.94+0.03+0.03%Vol 1 383 4231Y Perf -0.27%
Oct 17th, 2018 14:13
BID91.94 ASK91.97
Open91.82 Previous Close91.91
Pre-Market91.50 After-Trading91.90
 -0.41 -0.45%  -0.01 -0.01%
Target Price
109.58 
Analyst Rating
Moderate Buy 2.38
Potencial %
19.25 
Finscreener Ranking
★★     46.37
Insiders Trans % 3/6/12M
-100/-20/-88 
Value Ranking
★★     45.45
Insiders Value % 3/6/12M
-100/-68/-98 
Growth Ranking
★★★★     58.63
Insiders Shares Cnt. % 3/6/12M
-100/-67/-97 
Income Ranking
★★     43.08
Market Cap (mil)139 222 
Earnings Rating
Buy
Price Range Ratio 52wk %
16.49 
Earnings Date
2nd Nov 2018

Today's Price Range

90.8392.37

52wk Range

85.24125.86

5 Year PE Ratio Range

9.9072.10

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Month
-3.63%
3 Months
-3.67%
6 Months
-1.80%
1 Year
-0.27%
3 Years
64.29%
5 Years
103.44%

Quotes

Name / TickerPriceChg.Chg.%
ABBV91.940.03000.03
AAPL221.14-1.0100-0.45
GOOG1 114.66-6.6200-0.59
MSFT110.55-0.4500-0.41
XOM81.320.12000.15
WFC54.590.86001.60
JNJ139.643.08002.26
FB158.800.02000.01
GE12.300.20001.65
JPM110.191.57001.45
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 0.60
Current Ratio 0.80
Long Term Debt to Total Capital 0.90
Total Debt to Equity 10.49
Interest Coverage 7.60
Leverage Ratio -75.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin74.90
EBIT Margin30.10
EBITDA Margin35.40
Pre-tax Profit Margin25.50
Profit Margin20.18
ValuationValueIndustryS&P 500US Markets
PE Ratio 22.40
PB Ratio 39.31
PS Ratios 5.73
Price to Cash Flow 12.70
Price to Free Cash Flow 39.80
Cash Flow Per Share 7.13
Price to Tangible Book-2.99
Book Value per Share-2.23
Enterprise Value (in ths.)170 695 000
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)119.16
ROE last 12 Months 463.41
Return on Assets (5Y Avg) 6.91
ROA last 12 Months 9.86
Return on Capital (5Y Avg) 17.46
ROC last 12 Months 18.97
Return on invested Capital Q 6.01
Return on invested Capital Y14.24
Assets Turnover0.30
Receivables Turnover4.20
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)23 951 000
Revenue per Share 15.82
Revenue Growth 3 Years 5.12
Revenue Growth 5 Years 7.76
DividendsValueIndustryS&P 500US Markets
Dividend Yield 4.31
Dividend Rate 3.84
Dividend Growth 3 Years12.54
Dividend Growth 5 Years18.44

Earnings HistoryEstimateReportedSurprise %
Q02 20181.982.001.01
Q01 20181.801.873.89
Q04 20171.441.482.78
Q03 20171.391.411.44
Q02 20171.401.421.43
Q01 20171.261.281.59
Q04 20161.201.200.00
Q03 20161.211.210.00
Earnings Per EndEstimateRevision %Trend
9/2018 QR2.011.01Positive
12/2018 QR1.99-0.50Negative
12/2018 FY7.860.90Positive
12/2019 FY8.73-1.47Negative
Next Report Date2nd Nov 2018
Estimated EPS Next Report2.01
Estimates Count8
EPS Growth Next 5 Years %12.90
Volume Overview
Volume1 383 423
Shares Outstanding (in ths.)1 514 270
Trades Count7 647
Dollar Volume107 777 095
Avg. Volume7 032 903
Avg. Weekly Volume5 139 313
Avg. Monthly Volume5 063 938
Avg. Quarterly Volume5 632 666

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

58%42%

Bearish Bullish

58%42%

Bearish Bullish

63%37%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (38.46 %)
6 (37.50 %)
7 (41.18 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
7 (53.85 %)
9 (56.25 %)
9 (52.94 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
1 (7.69 %)
1 (6.25 %)
1 (5.88 %)
RatingModerate Buy
2.38
Moderate Buy
2.38
Moderate Buy
2.29

There are no comments yet.

News

x